Guosen Securities maintains Tiger Pharma's buy rating: the main business continues to recover and non-recurring returns are relatively high | China Business Blog

Aggregated China Business Blogs

2021-01-28

Guosen Securities maintains Tiger Pharma's buy rating: the main business continues to recover and non-recurring returns are relatively high

Aggregated Source: Caishen.Co

Caishen.Co delivers Primary Data for China`s Secondary Investment and Stock Markets. Full details at Caishen.Co.

Original URL: Click here to visit original article
Copyright Caishen.Co